NCT07643077Active, not recruiting
CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GREECE)
Source: ClinicalTrials.gov · Last updated 11 Jun 2026
Brief summary (registry, in English)
The effect of latanoprost with preservatives on the ocular surface microbiome
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 45 (estimated)
- First submitted
- 7 Jun 2026
- Start date
- 20 Mar 2024
- Primary completion date
- Aug 2026
- Lead sponsor
- University of Ioannina
- Diseases
- Glaucoma
- NCT number
- NCT07643077
What you commit to
- Study type: Observational
- Planned participants: 45
- From 20 Mar 2024 to the primary completion date, Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients' history of recent ocular surgery or trauma,
Other
- Patient with any type of conjunctivitis and ocular surface inflammation recent to the time of diagnosis
- Patients using topical antibiotics
- Contact lenses wearers
- Patients in other chronic treatments with eye drops
Who the study is looking for
- Newly diagnosed treatment naive glaucoma patients or those with ocular hypertension
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital of Ioannina Coordinator of this site? Confirm its status | Ioannina | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.